Viewing Study NCT00641095


Ignite Creation Date: 2025-12-24 @ 2:10 PM
Ignite Modification Date: 2026-01-18 @ 6:23 PM
Study NCT ID: NCT00641095
Status: COMPLETED
Last Update Posted: 2018-10-31
First Post: 2008-03-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma
Sponsor: University College, London
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module